cam a22 4 4500 294677615 CHVBK 20200922104932.0 131020s1993 sz a b||| 101 0 eng| 93015334 930315367 DE-101 9305713 DNLM 3-906390-04-7 (VCHA 978-3-906390-04-8 (VCHA 3-527-28486-9 (VCH 978-3-527-28486-3 (VCH 1-56081-252-4 (VCH 978-1-56081-252-4 1-56081-252-4 (IDSBB)006508840 (SNL)991002345369703976 (NEBIS)000700140 (OCoLC)27854747 (OCoLC)28850849 (OCoLC)29308523 (OCoLC)232534459 (Sz)52193-41snl_51 (Sz)vtls000052193 (Sz)000052193 DNLM/DLC ger DLC NLM UBA OCL BAKER NLGGC BTCTA YDXCP HEBIS DEBBG OCLCQ BDX GBVCP OCLCO OCLCF OCLCQ OCLCO OCL OCLCO OCLCQ OCLCO SzZuIDS BS/BE A228 rda RS401 .P47 1993 QV 744 P467 1993 615/.19 20 44.33 bcl 44.38 bcl VS 5000 rvk VS 5408 rvk YB 1700 rvk YB 1705 rvk International Symposium on Medicinal Chemistry (12 1992 Basel) (DE-588)2141575-4 Perspectives in medicinal chemistry Editors: Bernard Testa [und andere] Basel VHCA [1993] Weinheim New York VCH xii, 644 Seiten Illustrationen 25 cm Proceedings of the 12th International Symposium on Medicinal Chemistry Includes bibliographical references and index Chemistry, Pharmaceutical (DNLM)D002626 Drug Design (DNLM)D015195 Drug Therapy (DNLM)D004358 Pharmacology (DNLM)D010600 Pharmaceutical chemistry fast Medische chemie gtt Farmacochemie gtt Geneesmiddelen gtt Quimica farmaceutica larpcal Pharmazeutische Chemie (DE-588)4132158-3 gnd Klinische Chemie (DE-588)4135255-5 gnd Pharmaceutical chemistry Congresses Klinische Chemie idszbz ARZNEIMITTELREZEPTOREN (PHARMAKOLOGIE) ger (ETHUDK)000046931 ethudk ARZNEIMITTELVERGIFTUNG + GIFTIGE ARZNEIMITTEL ger (ETHUDK)000026901 ethudk ENZYMINHIBITION + ENZYMINAKTIVIERUNG (BIOCHEMIE) ger (ETHUDK)000022020 ethudk IONENKANÄLE (MEMBRANBIOLOGIE) ger (ETHUDK)000040413 ethudk MEDIZINISCHE BIOCHEMIE + MEDIZINISCHE MOLEKULARBIOLOGIE ger (ETHUDK)000021734 ethudk PHARMAKODYNAMIK + ARZNEIMITTELWIRKUNG (PHARMAKOLOGIE) ger (ETHUDK)000026617 ethudk PRODRUGS (ARZNEIFORMEN) ger (ETHUDK)000026804 ethudk PROTEINE, POLYPEPTIDE, ENZYME, ENZYMINHIBITOREN, PEPTIDE (PHARMAZIE) ger (ETHUDK)000026783 ethudk STRUKTUR-WIRKUNG BEZIEHUNG, CHEMISCHE EINFLÜSSE AUF ARZNEIMITTELWIRKUNG (PHARMAKOLOGIE) ger (ETHUDK)000026619 ethudk ZIELGERICHTETE ARZNEIMITTEL (PHARMAKOLOGIE) ger (ETHUDK)000039312 ethudk Chemistry, Pharmaceutical congresses Drug Design congresses Drug Therapy congresses Pharmaceutical chemistry Congresses Pharmacology congresses Congress (DNLM)D016423 Conference papers and proceedings fast Kongress Basel 1992 gnd Konferenzschrift Basel 1992/09 gnd-content Aufsatzsammlung idszbz 615.10:54 snl local 615.0(061.3) snl local sb 1995/17 18 snl-sb u MEDIZINISCHE BIOCHEMIE + MEDIZINISCHE MOLEKULARBIOLOGIE ger 61.001'577 nebis E1 u PROTEINE, POLYPEPTIDE, ENZYME, ENZYMINHIBITOREN, PEPTIDE (PHARMAZIE) ger 615.355 nebis E1 u ENZYMINHIBITION + ENZYMINAKTIVIERUNG (BIOCHEMIE) ger 577.151.042.2 nebis E1 u ARZNEIMITTELREZEPTOREN (PHARMAKOLOGIE) ger 615.015.44*2 nebis E1 u STRUKTUR-WIRKUNG BEZIEHUNG, CHEMISCHE EINFLÜSSE AUF ARZNEIMITTELWIRKUNG (PHARMAKOLOGIE) ger 615.015.11 nebis E1 u ZIELGERICHTETE ARZNEIMITTEL (PHARMAKOLOGIE) ger 615.031 nebis E1 u PRODRUGS (ARZNEIFORMEN) ger 615.014,9.015.4.014.43 nebis E1 u PHARMAKODYNAMIK + ARZNEIMITTELWIRKUNG (PHARMAKOLOGIE) ger 615.015.1/.8 nebis E1 u IONENKANÄLE (MEMBRANBIOLOGIE) ger 577.352.465,2 nebis E1 u ARZNEIMITTELVERGIFTUNG + GIFTIGE ARZNEIMITTEL ger 615.9.099.061 nebis E1 u BIOCHIMIE MÉDICALE + BIOLOGIE MOLÉCULAIRE MÉDICALE fre 61.001'577 nebis E1 u MEDICAL BIOCHEMISTRY + MEDICAL MOLECULAR BIOLOGY eng 61.001'577 nebis E1 u PROTÉINES, POLYPEPTIDES, ENZYMES, INHIBITEURS ENZYMATIQUES, PEPTIDES (PHARMACIE) fre 615.355 nebis E1 u PROTEINS, POLYPEPTIDES, ENZYMES, ENZYME INHIBITORS, PEPTIDES (PHARMACY) eng 615.355 nebis E1 u INHIBITION, INACTIVATION ENZYMATIQUE (BIOCHIMIE) fre 577.151.042.2 nebis E1 u ENZYME INHIBITION + ENZYME INACTIVATION (BIOCHEMISTRY) eng 577.151.042.2 nebis E1 u DRUG RECEPTORS (PHARMACOLOGY) eng 615.015.44*2 nebis E1 u RÉCEPTEURS DE MÉDICAMENTS (PHARMACOLOGIE) fre 615.015.44*2 nebis E1 u RELATION ENTRE STRUCTURE ET EFFETS DES MÉDICAMENTS (PHARMACOLOGIE) fre 615.015.11 nebis E1 u STRUCTURE-ACTIVITY RELATIONSHIP + CHEMICAL INFLUENCE ON DRUG ACTION (PHARMACOLOGY) eng 615.015.11 nebis E1 u MÉDICAMENTS CIBLÉS (PHARMACOLOGIE) fre 615.031 nebis E1 u TARGETED DRUGS (PHARMACOLOGY) eng 615.031 nebis E1 u PRODROGUES (FORMES DE MÉDICAMENTS) fre 615.014,9.015.4.014.43 nebis E1 u PRODRUGS (PHARMACEUTICALS) eng 615.014,9.015.4.014.43 nebis E1 u PHARMACODYNAMICS + DRUG ACTION (PHARMACOLOGY) eng 615.015.1/.8 nebis E1 u PHARMACODYNAMIQUE + ACTION DES MÉDICAMENTS (PHARMACOLOGIE) fre 615.015.1/.8 nebis E1 u CANAUX À IONS (BIOLOGIE DES MEMBRANES) fre 577.352.465,2 nebis E1 u ION CHANNELS (MEMBRANE BIOLOGY) eng 577.352.465,2 nebis E1 u INTOXICATION PAR MÉDICAMENTS + MÉDICAMENTS TOXIQUES fre 615.9.099.061 nebis E1 u PHARMACOTOXICOLOGY + TOXIC MEDICAMENTS eng 615.9.099.061 nebis E1 Testa Bernard Herausgeber edt Table of contents http://www.gbv.de/dms/bowker/toc/9783527284863.pdf BK020800 XK020000 XK020000 ch SzZuIDS BS/BE Kongress = Congrès 1992/09 Basel SNL NB001 NB001 N 219458 NB10010 IDSBB A228 A228 FH CHE BIO 12 Geschenk/Nachlass 06.06.2016 IDSBB 111 2- International Symposium on Medicinal Chemistry (12 1992 Basel) (DE-588)2141575-4 IDSBB 700 1- Testa Bernard Herausgeber edt IDSBB 856 41 Table of contents http://www.gbv.de/dms/bowker/toc/9783527284863.pdf SNL 700 1- Testa Bernard SNL 711 2- International Symposium on Medicinal Chemistry (12 1992 Basel) SNL 711 2- Kongress (1992 Basel, BS) NEBIS 700 1- Testa Bernard NEBIS 711 2- International Symposium on Medicinal Chemistry (DE-588)1091906149